The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. A variety of strategies can be employed enhance antibody titer, such as process parameter optimization, genetic engineering, and the use of perfusion technologies. Fine-tuning culture conditio